Cardiovascular wellbeing has been dramatically affected by SARS-CoV-2, the reason for the COVID-19 pandemic. There is a greater risk of morbidity and death in individuals with preexisting heart diseases. Clinical… Click to show full abstract
Cardiovascular wellbeing has been dramatically affected by SARS-CoV-2, the reason for the COVID-19 pandemic. There is a greater risk of morbidity and death in individuals with preexisting heart diseases. Clinical syndromes of the acute coronary syndrome, acute myocardial injury, myocarditis, arrhythmias, heart failure, and venous thromboembolism can, directly and indirectly, affect the heart. There may also be adverse heart effects of specific therapeutics under review for COVID-19. The RAAS mechanism in virus replication makes it essential to understand the consequences of the system-modulating medications. For optimum patient care, detailed knowledge of specific cardiovascular symptoms of COVID-19 and the role of RAAS in the prognosis of COVID-19 disease is necessary.
               
Click one of the above tabs to view related content.